The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Role of interferon regulatory factor 1 in induction of nitric oxide synthase.
Open accessAbstract
Interferon gamma (IFN-gamma) interacts synergistically with bacterial lipopolysaccharide (LPS) to induce transcription of iNOS, the isoform of nitric oxide synthase whose activity is independent of elevated Ca2+ and exogenous calmodulin. To define a cis-acting element mediating IFN-gamma-dependent synergy, we made deletions in iNOS promoter constructs fused to reporter genes, transfected RAW 264.7 macrophages, and treated the cells with IFN-gamma and/or LPS. This analysis implicated the region from positions -951 to -911, a cluster of four enhancer elements known to bind IFN-gamma-responsive transcription factors, including an interferon regulatory factor binding site (IRF-E) at nucleotides -913 to -923. Site-specific substitution of two conserved nucleotides within IRF-E in the context of the full-length iNOS promoter ablated IFN-gamma's contribution to synergistic enhancement of transcription. Electromobility shift assays performed with a probe containing IRF-E revealed the existence of a complex in nuclei of RAW 264.7 macrophages that was present only after treatment with IFN-gamma, which reacted specifically with anti-IRF-1 immunoglobulin G and which included a species migrating at 40-45 kD, consistent with the apparent molecular weight of murine IRF-1. Thus, the synergistic contribution of IFN-gamma to transcription of iNOS in RAW 264.7 macrophages requires that IRF-1 bind to IRF-E in the iNOS promoter. In conjunction with the work of Kamijo et al. (Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, K. S. Im, T. Kimura, S. Green et al. 1994. Science [Wash. DC]. 263:1612), these findings identify iNOS as the first gene that requires IRF-1 for IFN-gamma-dependent transcriptional regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Self-citationSchreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,826
Self-citationCloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Self-citationCloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Self-citationRegulation of biosynthesis of nitric oxide.
Nathan, C., & Xie, Q. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36703-0 · Cited by 1,669
Self-citationXie, Q. W., Whisnant, R., & Nathan, C. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1779 · Cited by 1,118
Self-citationLowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,064
Lamas, S., Marsden, P. A., Li, G. K., Tempst, P., & Michel, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6348 · Cited by 982
Cited by
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Self-citationNitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918
Self-citationIRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Self-citationBright and dark sides of nitric oxide in ischemic brain injury
Iadecola, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10074-6 · Cited by 1,046
The Cell Biology of Phagocytosis
Flannagan, R. S., Jaumouillé, V., & Grinstein, S. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132445 · Cited by 1,023
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826
Regulation of the expression of inducible nitric oxide synthase
Kleinert, H., Pautz, A., Linker, K., & Schwarz, P. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.030 · Cited by 705
Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1755 · Cited by 673
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.
Ma, X., Chow, J. M., Gri, G., Carra, G., Gerosa, F., Wolf, S. F., Dzialo, R., & Trinchieri, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.147 · Cited by 648
Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W., & Varesio, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1683 · Cited by 626
Tsai, S., Lin‐Shiau, S., & Lin, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702357 · Cited by 511
The high-output nitric oxide pathway: role and regulation
Xie, Q.-W., & Nathan, C. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.576 · Cited by 510
Self-citationThe growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480
Isoforms of nitric oxide synthase
Förstermann, U., Gath, I., Schwarz, P., Closs, E. I., & Kleinert, H. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00181-6 · Cited by 477
Nitric oxide synthase: expression and expressional control of the three isoforms
F�rstermann, U., & Kleinert, H. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00172772 · Cited by 466
Regulation of the Expression of Inducible Nitric Oxide Synthase
Kleinert, H., Schwarz, P. M., & Förstermann, U. (2003) · Biological Chemistry · doi:10.1515/bc.2003.152 · Cited by 423
Taylor, B. S., de Vera, M. E., Ganster, R. W., Wang, Q., Shapiro, R. A., Morris, S. M., Billiar, T. R., & Geller, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15148 · Cited by 413
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado, M., Pozo, D., & Ganea, D. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.7 · Cited by 412
de Vera, M. E., Shapiro, R. A., Nussler, A. K., Mudgett, J. S., Simmons, R. L., Morris, S. M., Billiar, T. R., & Geller, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1054 · Cited by 399
Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Röllinghoff, M., Gresser, I., & Bogdan, C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80460-4 · Cited by 368
Role of nitric oxide in parasitic infections
James, S. L. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.4.533-547.1995 · Cited by 364
Arginine-dependent immune responses
Martí i Líndez, A.-A., & Reith, W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03828-4 · Cited by 354
Chan, E. D., & Riches, D. W. H. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c441 · Cited by 353
Regulation of Inducible Nitric Oxide Synthase Gene in Glial Cells
Saha, R. N., & Pahan, K. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.929 · Cited by 353
Feng, G.-J., Goodridge, H. S., Harnett, M. M., Wei, X.-Q., Nikolaev, A. V., Higson, A. P., & Liew, F.-Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6403 · Cited by 335
Molecular biology of nitric oxide synthases
Geller, D. A., & Billiar, T. R. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005940202801 · Cited by 330
Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production
Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., & Murray, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2173 · Cited by 324
Chen, Y.-C., Yang, L.-L., & Lee, T. J.-F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00255-0 · Cited by 323
Iadecola, C., Zhang, F., Casey, R., Clark, H. B., & Ross, M. E. (1996) · Stroke · doi:10.1161/01.str.27.8.1373 · Cited by 322
Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB
Ganster, R. W., Taylor, B. S., Shao, L., & Geller, D. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151239498 · Cited by 321
Martin, T., Cardarelli, P. M., Parry, G. C. N., Felts, K. A., & Cobb, R. R. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270508 · Cited by 317
Macrophages and post-burn immune dysfunction
Schwacha, M. G. (2003) · Burns · doi:10.1016/s0305-4179(02)00187-0 · Cited by 310
Gao, J., Morrison, D. C., Parmely, T. J., Russell, S. W., & Murphy, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1226 · Cited by 303
Wadsworth, T. L., & Koop, D. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00002-7 · Cited by 302
Neish, A. S., Read, M. A., Thanos, D., Pine, R., Maniatis, T., & Collins, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2558 · Cited by 298
McKee, C. M., Lowenstein, C. J., Horton, M. R., Wu, J., Bao, C., Chin, B. Y., Choi, A. M. K., & Noble, P. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8013 · Cited by 283
Activating a collaborative innate-adaptive immune response to control metastasis
Sun, L., Kees, T., Almeida, A. S., Liu, B., He, X.-Y., Ng, D., Han, X., Spector, D. L., McNeish, I. A., Gimotty, P., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.005 · Cited by 267
Role of nitric oxide after brain ischaemia
Moro, M. A., Cárdenas, A., Hurtado, O., Leza, J. C., & Lizasoain, I. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.02.011 · Cited by 266
Kröger, A., Köster, M., Schroeder, K., Hauser, H., & Mueller, P. P. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452610 · Cited by 265
Chen, J.-C., Ho, F.-M., Chao, P.-D. L., Chen, C.-P., Jeng, K.-C. G., Hsu, H.-B., Lee, S.-T., Wu, W. T., & Lin, W.-W. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.005 · Cited by 265
Nitric Oxide Synthases and Cardiac Muscle: Autocrine and Paracrine Influences
Balligand, J.-L., & Cannon, P. J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1846 · Cited by 260
Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells
Morris, S. M., Kepka-Lenhart, D., & Chen, L.-C. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e740 · Cited by 252
Maciejewski, J. P., Selleri, C., Sato, T., Cho, H. J., Keefer, L. K., Nathan, C. F., & Young, N. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118094 · Cited by 209
Self-citationMelillo, G., Taylor, L. S., Brooks, A., Musso, T., Cox, G. W., & Varesio, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12236 · Cited by 201
Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
Heinecke, J. L., Ridnour, L. A., Cheng, R. Y. S., Switzer, C. H., Lizardo, M. M., Khanna, C., Glynn, S. A., Hussain, S. P., Young, H. A., Ambs, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401799111 · Cited by 177
“IRF1 is also necessary for transcriptional activation of the NOS2 gene (29), and this finding implicates an IFN signature as a key mediator of NOS2 expression and downstream effects in these aggressive breast tumors (4).”
BackgroundDlaska, M., & Weiss, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6171 · Cited by 176
Modulation of mRNA stability as a novel therapeutic approach
Eberhardt, W., Doller, A., Akool, E.-S., & Pfeilschifter, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.002 · Cited by 173
Vazquez-Torres, A., Vallance, B. A., Bergman, M. A., Finlay, B. B., Cookson, B. T., Jones-Carson, J., & Fang, F. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6202 · Cited by 173
Fehr, T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M., Bachmann, M. F., Mak, T. W., Horak, I., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.921 · Cited by 162
Interferon Regulatory Factor 1 Is Required for Mouse Gbp Gene Activation by Gamma Interferon
Briken, V., Ruffner, H., Schultz, U., Schwarz, A., Reis, L. F. L., Strehlow, I., Decker, T., & Staeheli, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.975 · Cited by 143
“In the cases of the mouse Gbp genes (reference 22 and this work) and the gene for iNOS (22, 26), the transcription factor required for induction by IFN-g is IRF-1.”
BackgroundDelay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide
Axelrod, S., Oschkinat, H., Enders, J., Schlegel, B., Brinkmann, V., Kaufmann, S. H. E., Haas, A., & Schaible, U. E. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01147.x · Cited by 141
Barton, C. H., Whitehead, S. H., & Blackwell, J. M. (1995) · Molecular Medicine · doi:10.1007/bf03401551 · Cited by 129
Uetani, K., Der, S. D., Zamanian-Daryoush, M., de la Motte, C., Lieberman, B. Y., Williams, B. R. G., & Erzurum, S. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.988 · Cited by 100
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
Fritsche, G., Dlaska, M., Barton, H., Theurl, I., Garimorth, K., & Weiss, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1994 · Cited by 86
“iNOS by IFN- (37, 38), the up-regulation of iNOS in Nramp1resistant cells is correlated to an increased response of these cells to stimulation with IFN- .”
BackgroundInterferon Regulatory Factor-2 Directs Transcription from the gp91 Promoter
Luo, W., & Skalnik, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23445 · Cited by 67
Wu, F., Tyml, K., & Wilson, J. X. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02804-1 · Cited by 67
Regulation of IFN Consensus Sequence Binding Protein Expression in Murine Macrophages
Kantakamalakul, W., Politis, A. D., Marecki, S., Sullivan, T., Ozato, K., Fenton, M. J., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7417 · Cited by 61
Metadata
- Authors
- Martin, E., Nathan, C., & Xie, Q. W.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-09-01
- Volume
- 180
- Issue
- 3
- Pages
- 977-984
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2119092109
- Cited by
- 477
- References
- 41
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.